dc.contributor.author | Taylor, PN | |
dc.contributor.author | Iqbal, A | |
dc.contributor.author | Minassian, C | |
dc.contributor.author | Sayers, A | |
dc.contributor.author | Draman, MS | |
dc.contributor.author | Greenwood, R | |
dc.contributor.author | Hamilton, W | |
dc.contributor.author | Okosieme, O | |
dc.contributor.author | Panicker, V | |
dc.contributor.author | Thomas, SL | |
dc.contributor.author | Dayan, Colin M. | |
dc.date.accessioned | 2014-08-13T14:27:17Z | |
dc.date.issued | 2014-01 | |
dc.description.abstract | Rates of thyroid hormone prescribing in the United States and the United Kingdom have increased substantially. If some of the increase is due to lowering the thyrotropin threshold for treatment, this may result in less benefit and greater harm. | en_GB |
dc.description.sponsorship | Medical Research Council | en_GB |
dc.identifier.citation | JAMA Internal Medicine, 2014, vol. 174, issue 1, pp. 32 - 39 | en_GB |
dc.identifier.doi | 10.1001/jamainternmed.2013.11312 | |
dc.identifier.uri | http://hdl.handle.net/10871/15363 | |
dc.language.iso | en | en_GB |
dc.publisher | American Medical Association | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/24100714 | en_GB |
dc.rights.embargoreason | Publisher's policy | en_GB |
dc.rights | Copyright 2014 American Medical Association | en_GB |
dc.subject | Aged | en_GB |
dc.subject | Cohort Studies | en_GB |
dc.subject | Drug Therapy | en_GB |
dc.subject | Female | en_GB |
dc.subject | Great Britain | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Hypothyroidism | en_GB |
dc.subject | Male | en_GB |
dc.subject | Middle Aged | en_GB |
dc.subject | Odds Ratio | en_GB |
dc.subject | Retrospective Studies | en_GB |
dc.subject | Risk Assessment | en_GB |
dc.subject | Thyrotropin | en_GB |
dc.subject | Thyroxine | en_GB |
dc.subject | Treatment Outcome | en_GB |
dc.title | Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2015-01-01T04:00:08Z | |
dc.identifier.issn | 2168-6106 | |
exeter.place-of-publication | United States | |
dc.description | This is the author's post-print version of the article, which has been published in final form in JAMA Internal Medicine, and can be accessed via the DOI in this record. | en_GB |
dc.identifier.journal | JAMA Internal Medicine | en_GB |